{"name":"Mural Oncology, Inc","slug":"mural-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ALKS 4230","genericName":"ALKS 4230","slug":"alks-4230","indication":"Other","status":"phase_1"},{"name":"Nemvaleukin","genericName":"Nemvaleukin","slug":"nemvaleukin","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"ALKS 4230","genericName":"ALKS 4230","slug":"alks-4230","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Nemvaleukin","genericName":"Nemvaleukin","slug":"nemvaleukin","phase":"discontinued","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5yUlFkZkpRQVdTS05PY2hiYzFpVFgyYUs0NWc1dDcxbDh6dm1ldlJLbG95aWNETmJQaGhjeGRNbFBOeHdmMkdmSGphVlY4WTZpVlE5Ym1Md20zeWFxODFKaW9IdmlNVHRlTlZ3N2tn?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Mural Oncology PLC (MURA) - Stock Titan","headline":"If You Invested $1,000 in Mural Oncology PLC (MURA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQUkJBSFcwbHFrdlJBUnduVE9WTEtJM3NvWjF3SkIwdENXd1A4b1dGcE9pY3N3M2piY1ctQUpyVXlOYk80dlQ1dlU4MVFqMDZ0V1NiUjdPTnZ3MndacHNoaWV5azdueGJ1Tzh3dk9JSWo2Z0hJWFlkRWpvellxbmo0Y2RPUXdpMjlCNi1OYUE0MEZFbW8?oc=5","date":"2026-02-05","type":"regulatory","source":"BioWorld News","summary":"Cancer index surges 72% as Terns, Olema lead gains - BioWorld News","headline":"Cancer index surges 72% as Terns, Olema lead gains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQUDlnV1BwYXlMMlJfUU1ERjh6LVFTblFCYTNFekF5ODNKaHQ3M194dkRBb3E1Ul9ZQ1FsQ1pJMWp1VmhnYVltcUxFXzFrMDlsd1dUOVZ4TnVHejJYZUZLTHY4T0NpMWd3LVZFbnQwUlJFQjZKdlY5TzY5c0IzOHRLcU1GaXFiakhkOWQ4ZFRyMW01Zw?oc=5","date":"2025-12-05","type":"deal","source":"finance.yahoo.com","summary":"XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - finance.yahoo.com","headline":"XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5XUkI5NGp4X0pOYW01Rk1KTU94SENqTXkxVzNac05WWHRUeU5aT3dXQzNpclVTS3dFaWNtTmRHTVlKbXRHMVJBVE5HZlh3clE4MTVObGtLbF9xc0NQZ05rRWhUOA?oc=5","date":"2025-10-08","type":"pipeline","source":"TradingKey","summary":"MURA|Mural Oncology PLC|Price:2.040| - TradingKey","headline":"MURA|Mural Oncology PLC|Price:2.040|","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBYRUZVQmw3V0xUUUd0ZzlnS01fVFE1MHBiOUV6MzQ0TS1nQmphU0cwMFlFdFdvWGlCcHJYVzVGdmQyMUY0Xzk4VktDR0hzNGNGT05aeGVmSnRjT1RDRnJ0dmlMUjlYcnFKeDBaT2VTaVU?oc=5","date":"2025-08-21","type":"trial","source":"Oncology Pipeline","summary":"Xoma buys a cheap Mural | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Xoma buys a cheap Mural | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQYlhTcnhPd0RiTlNydDdGNlMxcElyR2phM1FzMVV6RENuTXBXQ1RaUTRmWWlsdWNZNF9janJsbEJFWDhRSm5uN1N3czhialdvTXQxMmVwZVF1SEw1NGl4Y3lxMFo3OGNDdnVxZ3B4Q1poZDBBNWNSeFhiQmNobVRoeU5OTEtscU9WTldqeHVDZjJlZ1FpOXMwT25B?oc=5","date":"2025-08-20","type":"deal","source":"BioPharma Dive","summary":"Xoma, a drug royalty specialist, buys another ‘zombie’ biotech - BioPharma Dive","headline":"Xoma, a drug royalty specialist, buys another ‘zombie’ biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3ZxaWVCOEdjdXEwN0lWZzQtbE93SGVLdjBnRXF2V2R3cWwyZHhhU2dORTV5dFp4anRiYmltcjRIZkRmaWxuQTRCRTJDOU9pMkpSMzA0aE9QalByRklmTE9TNk9lOEJtWmwybDhTZHRsd3BBcVp4RXhFM3Fha3VwS3NJSFNUa2VKZVU1NFU4VUJnZWNnbUhDcEFTeFlhUUJu?oc=5","date":"2025-08-20","type":"pipeline","source":"Fierce Biotech","summary":"Xoma adds fading Mural Oncology to portfolio of struggling biotechs - Fierce Biotech","headline":"Xoma adds fading Mural Oncology to portfolio of struggling biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMm9XVU1hMFQ2emdfRU5TSmlJT29jNnlnaXMzLU5ocnFFd1dlMFFRN0dNTXc0QnR2X2cxbzJpbG1vQUlNZ1B6V1lQS2J6R0stYmJJTjluaHFoeTBvaDNWNXhGZFhwRi1lMG14NC01Nk1ybUQxZDVpNFNndEtZeXg1V014ZVB2Q0N4Y3Q2Q2JnVXhCaHBlRzN4ZUJ1NW5IdkNJZUhZTjQyRUVHQQ?oc=5","date":"2025-08-20","type":"deal","source":"The Business Journals","summary":"After culling 90% of staff, Waltham biotech finds buyer - The Business Journals","headline":"After culling 90% of staff, Waltham biotech finds buyer","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-05","type":"pipeline","source":"simplywall.st","summary":"Mural Oncology (NASDAQ:MURA) Will Have To Spend Its Cash Wisely - simplywall.st","headline":"Mural Oncology (NASDAQ:MURA) Will Have To Spend Its Cash Wisely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQbGZlajNmaWROSjJ6WnpmdUJ6U1lrbVhhSnpfOUcxdExkY09Yb0VMcGd3ZFZrd3Bad0ZTM2ctQWkyZE10OGgySEtpUGFsQWI1MDJUSUR0emRzREFkcUo3SXRWWDRZQS1HSzY0QlB2cC10bzM1VFZMVXZLeWxXcWR0Y041REg3VmJMRjc1dDBuTG9HQ0JL?oc=5","date":"2025-04-17","type":"pipeline","source":"Boston.com","summary":"Mass. biotech company cuts 90% of workforce - Boston.com","headline":"Mass. biotech company cuts 90% of workforce","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNeWt0R3dsNlJIWk4tWXpuSlYwb3k0UTlvTHlaWXVhbjBTU25Dc3lWYWhhcFZSX0Y3OEQ4dnBKU2w4YXJra2pxSTNFYllhRHl5UERjc3pSLUg3WXhHNjUzNWlxeHZtNUl1VWlsRVZ4aFFxZWptU1B3ajB2V21xMktvLXhFUjBxTkQ0dS05dzEtTGtnaTdySjVEOHJqRGJaTzQyaUxLa1N3?oc=5","date":"2025-04-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mural shuts down lead programme and slashes 90% of staff - Pharmaceutical Technology","headline":"Mural shuts down lead programme and slashes 90% of staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNYXlqcW9fR2V5aExnem9ueVNUOXRoTGd5eEhwRDlhVkQ2NTRHem56b3oySjJmVmpwMTNXRi1FRXhTeS15N2ExWmlfWmRibVBSb2w2OGdQdU05ajJrUHNEOTR3TDYtdmFIa3A3N3pWdFc1SVFwVUZNeU5KN0FBLUM1QVgzbTdHeWppTDZ5M2dzMHpTbXFPRDRtRFB2QldxQ0hjR3lFb2lXd1ZFTHJBRVFoU3hTdlE?oc=5","date":"2025-03-25","type":"trial","source":"Clinical Trials Arena","summary":"Mural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57% - Clinical Trials Arena","headline":"Mural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%","sentiment":"negative"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"discontinued":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}